{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:05:44Z","timestamp":1790996744478,"version":"4.1.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mesenchymal stromal cells (MSCs), owing to their regenerative and immunomodulatory properties, have emerged as a potential therapeutic option for disorders affecting the cornea and ocular surface. Early-phase clinical studies have begun to demonstrate the safety and, to some extent, efficacy of MSC-based therapies in conditions such as dry eye disease, persistent corneal epithelial defects, ocular chemical injuries, corneal scarring, keratoconus, and limbal stem cell deficiency. However, evidence from some studies suggests that MSC-related improvements may be short-lived. Currently, the appropriate clinical indications, delivery methods, and long-term outcomes remain unclear, necessitating further laboratory and clinical investigations. In this review, we summarize published and ongoing clinical studies on the therapeutic applications of MSCs for ocular surface diseases, including our own group\u2019s experience. We critically evaluate the strengths and limitations of existing studies and highlight gaps and opportunities in this evolving field.<\/jats:p>","DOI":"10.1093\/stmcls\/sxaf048","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T07:51:29Z","timestamp":1751529089000},"source":"Crossref","is-referenced-by-count":7,"title":["Clinical evidence and critical review of mesenchymal stromal cells for corneal and ocular surface diseases"],"prefix":"10.1093","volume":"43","author":[{"given":"Grace C","family":"Tu","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago , Chicago, IL 60612,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyedehfatemeh","family":"Ghalibafan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago , Chicago, IL 60612,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Abedi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago , Chicago, IL 60612,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte E","family":"Joslin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago , Chicago, IL 60612,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Dana","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School , Boston, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiman","family":"Hematti","sequence":"additional","affiliation":[{"name":"Department of Medicine, Medical College of Wisconsin , Milwaukee, WI 53226,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1489-0724","authenticated-orcid":false,"given":"Ali R","family":"Djalilian","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago , Chicago, IL 60612,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"2025092619025145800_sxaf048-B1","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jcrs.2010.12.037","article-title":"Anatomy and physiology of the cornea","volume":"37","author":"DelMonte","year":"2011","journal-title":"J CataractRefract Surg."},{"key":"2025092619025145800_sxaf048-B2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00441-014-2032-4","article-title":"Roles of limbal microvascular net and limbal stroma in regulating maintenance of limbal epithelial stem cells","volume":"359","author":"Huang","year":"2015","journal-title":"Cell Tissue Res."},{"key":"2025092619025145800_sxaf048-B3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/14712598.2023.2175605","article-title":"Applications of mesenchymal stem cells in ocular surface diseases: sources and routes of delivery","volume":"23","author":"Soleimani","year":"2023","journal-title":"Expert Opin Biol Ther"},{"key":"2025092619025145800_sxaf048-B4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ajo.2018.11.001","article-title":"Amniotic membrane transplantation in acute severe ocular chemical injury: a randomized clinical trial","volume":"199","author":"Eslani","year":"2019","journal-title":"Am J Ophthalmolo."},{"key":"2025092619025145800_sxaf048-B5","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12886-016-0346-6","article-title":"Effectiveness of bandage contact lens application in corneal epithelialization and pain alleviation following corneal transplantation; prospective, randomized clinical trial","volume":"16","author":"Shimazaki","year":"2016","journal-title":"BMC Ophthalmol."},{"key":"2025092619025145800_sxaf048-B6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ophtha.2019.08.020","article-title":"Topical recombinant human nerve growth factor (Cenegermin) for neurotrophic keratopathy: a multicenter randomized vehicle-controlled pivotal trial","volume":"127","author":"Pflugfelder","year":"2020","journal-title":"Ophthalmology."},{"key":"2025092619025145800_sxaf048-B7","doi-asserted-by":"crossref","first-page":"11510","DOI":"10.3390\/ijms231911510","article-title":"Therapeutic potential of mesenchymal stem cell-secreted factors on delay in corneal wound healing by nitrogen mustard","volume":"23","author":"An","year":"2022","journal-title":"Int J Mol Sci."},{"key":"2025092619025145800_sxaf048-B8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jtos.2024.11.001","article-title":"Adipose-derived mesenchymal stromal cells: a study on safety and efficacy in ocular inflammation","volume":"34","author":"Rusch","year":"2024","journal-title":"Ocul Surf."},{"key":"2025092619025145800_sxaf048-B9","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s12015-022-10369-1","article-title":"A brief overview of global trends in MSC-based cell therapy","volume":"18","author":"Jovic","year":"2022","journal-title":"Stem Cell Rev Rep."},{"key":"2025092619025145800_sxaf048-B10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II Epidemiology Report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf."},{"key":"2025092619025145800_sxaf048-B11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.survophthal.2024.07.008","article-title":"Potential applications of mesenchymal stem cells in ocular surface immune-mediated disorders","volume":"70","author":"Surico","year":"2024","journal-title":"Surv Ophthalmol"},{"key":"2025092619025145800_sxaf048-B12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jtos.2020.11.013","article-title":"Safety and feasibility of mesenchymal stem cell therapy in patients with aqueous deficient dry eye disease","volume":"19","author":"M\u00f8ller-Hansen","year":"2021","journal-title":"Ocul Surf."},{"key":"2025092619025145800_sxaf048-B13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtos.2023.11.007","article-title":"Allogeneic mesenchymal stem cell therapy for dry eye disease in patients with Sj\u00f6gren\u2019s syndrome: A randomized clinical trial","volume":"31","author":"M\u00f8ller-Hansen","year":"2024","journal-title":"Ocul Surf."},{"key":"2025092619025145800_sxaf048-B14","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41419-021-03839-w","article-title":"Short lifespan of syngeneic transplanted MSC is a consequence of in vivo apoptosis and immune cell recruitment in mice","volume":"12","author":"Preda","year":"2021","journal-title":"Cell Death Dis."},{"key":"2025092619025145800_sxaf048-B15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s13287-025-04292-8","article-title":"A first-in-human, prospective pilot trial of umbilical cord-derived mesenchymal stem cell eye drops therapy for patients with refractory non-Sj\u00f6gren\u2019s and Sj\u00f6gren\u2019s syndrome dry eye disease","volume":"16","author":"Zhang","year":"2025","journal-title":"Stem Cell Res Ther."},{"key":"2025092619025145800_sxaf048-B16","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1038\/mt.2012.208","article-title":"Mesenchymal stromal cells treatment attenuates dry eye in patients with chronic graft-versus-host disease","volume":"20","author":"Weng","year":"2012","journal-title":"Mol Ther"},{"key":"2025092619025145800_sxaf048-B17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jtos.2016.09.002","article-title":"Current and upcoming therapies for ocular surface chemical injuries","volume":"15","author":"Baradaran-Rafii","year":"2017","journal-title":"Ocul Surf."},{"key":"2025092619025145800_sxaf048-B18","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1167\/iovs.18-24803","article-title":"Effect of human corneal mesenchymal stromal cell-derived exosomes on corneal epithelial wound healing","volume":"59","author":"Samaeekia","year":"2018","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"2025092619025145800_sxaf048-B19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jtos.2021.07.008","article-title":"Safety and feasibility of subconjunctival injection of mesenchymal stem cells for acute severe ocular burns: A single-arm study","volume":"22","author":"Liang","year":"2021","journal-title":"Ocul Surf."},{"key":"2025092619025145800_sxaf048-B20","first-page":"163","article-title":"Persistent corneal epithelial defects: a review article","volume":"8","author":"Vaidyanathan","year":"2019","journal-title":"Med Hypothesis, Discov Innov Ophthalmol J"},{"key":"2025092619025145800_sxaf048-B21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jtos.2014.12.005","article-title":"Novel therapy to treat corneal epithelial defects: a hypothesis with growth hormone","volume":"13","author":"Wirostko","year":"2015","journal-title":"Ocul Surf"},{"key":"2025092619025145800_sxaf048-B22","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ajo.2020.05.035","article-title":"Prevalence of persistent corneal epithelial defects in chronic ocular graft-versus-host disease","volume":"218","author":"Sinha","year":"2020","journal-title":"Am J Ophthalmol."},{"key":"2025092619025145800_sxaf048-B23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4252\/wjsc.v6.i3.296","article-title":"Mesenchymal stem cells: potential role in corneal wound repair and transplantation","volume":"6","author":"Li","year":"2014","journal-title":"World J Stem Cells."},{"key":"2025092619025145800_sxaf048-B24","first-page":"2360","article-title":"Safety and efficacy of alginate-preserved human limbus-derived mesenchymal stem cells for the treatment of superficial corneal pathologies","volume":"64","author":"Basu","year":"2023","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"2025092619025145800_sxaf048-B25","first-page":"3455","article-title":"Limbal stromal stem cell therapy for acute and chronic superficial corneal pathologies: one-year outcomes","volume":"59","author":"Funderburgh","year":"2018","journal-title":". Invest Ophthalmol Visual Sci"},{"key":"2025092619025145800_sxaf048-B26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jtos.2025.05.009","article-title":"Safety of subconjunctival injection of mesenchymal stromal cells in persistent corneal epithelial disease\u2014a Phase 1b clinical trial","author":"Tu","year":"2025","journal-title":"Ocul Surf"},{"key":"2025092619025145800_sxaf048-B27","doi-asserted-by":"crossref","first-page":"1524595","DOI":"10.3389\/fopht.2024.1524595","article-title":"Diagnostic approach to limbal stem cell deficiency","volume":"4","author":"Lent-Schochet","year":"2024","journal-title":"Front Ophthalmol"},{"key":"2025092619025145800_sxaf048-B28","first-page":"111","article-title":"Concise review: bioengineering of limbal stem cell niche","volume":"10","author":"Soleimani","year":"2023","journal-title":"Bioengineering (Basel, Switzerland)."},{"key":"2025092619025145800_sxaf048-B29","first-page":"18","article-title":"A proof-of-concept clinical trial using mesenchymal stem cells for the treatment of corneal epithelial stem cell deficiency","volume":"206","author":"Calonge","year":"2019","journal-title":"Transl Res J Lab Clin Med."},{"key":"2025092619025145800_sxaf048-B30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/02713683.2023.2297342","article-title":"Long-term effects of adipose-derived stem cells for the treatment of bilateral limbal stem cell deficiency","volume":"49","author":"Boto de Los Bueis","year":"2024","journal-title":"Curr Eye Res."},{"key":"2025092619025145800_sxaf048-B31","doi-asserted-by":"crossref","first-page":"101559","DOI":"10.1016\/j.clae.2021.101559","article-title":"Keratoconus: An updated review","volume":"45","author":"Santodomingo-Rubido","year":"2022","journal-title":"Cont Lens Anterior Eye."},{"key":"2025092619025145800_sxaf048-B32","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.2147\/OPTH.S392665","article-title":"Keratoconus diagnosis and treatment: recent advances and future directions","volume":"17","author":"Bui","year":"2023","journal-title":"Clin Ophthalmol (Auckland, NZ)."},{"key":"2025092619025145800_sxaf048-B33","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/ICO.0000000000001228","article-title":"Cellular therapy with human autologous adipose-derived adult stem cells for advanced keratoconus","volume":"36","author":"Ali\u00f3 Del Barrio","year":"2017","journal-title":"Cornea."},{"key":"2025092619025145800_sxaf048-B34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ajo.2017.10.026","article-title":"Corneal stroma enhancement with decellularized stromal laminas with or without stem cell recellularization for advanced keratoconus","volume":"186","author":"Ali\u00f3 Del Barrio","year":"2018","journal-title":"Am J Ophthalmol."},{"key":"2025092619025145800_sxaf048-B35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1167\/iovs.61.4.22","article-title":"Corneal stroma cell density evolution in keratoconus corneas following the implantation of adipose mesenchymal stem cells and corneal laminas: an in vivo confocal microscopy study","volume":"61","author":"El Zarif","year":"2020","journal-title":"Invest Ophthalmol Visual Sci."},{"key":"2025092619025145800_sxaf048-B36","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/ICO.0000000000002646","article-title":"Corneal stromal regeneration therapy for advanced keratoconus: long-term outcomes at 3 years","volume":"40","author":"El Zarif","year":"2021","journal-title":"Cornea."}],"container-title":["Stem Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/stmcls\/advance-article-pdf\/doi\/10.1093\/stmcls\/sxaf048\/63713333\/sxaf048.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/43\/10\/sxaf048\/63713333\/sxaf048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/43\/10\/sxaf048\/63713333\/sxaf048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T23:03:01Z","timestamp":1758927781000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stmcls\/article\/doi\/10.1093\/stmcls\/sxaf048\/8195744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,9,17]]}},"URL":"https:\/\/doi.org\/10.1093\/stmcls\/sxaf048","relation":{},"ISSN":["1066-5099","1549-4918"],"issn-type":[{"value":"1066-5099","type":"print"},{"value":"1549-4918","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,7,9]]},"article-number":"sxaf048"}}